Background: Understanding the distribution of high-sensitivity C-reactive protein (CRP) and its relations with classic cardiovascular risk factors in specific populations is important for further diagnostic use. Methods: We studied 1157 adult subjects (652 women and 505 men) participating in the Health Study of Catalonia. CRP concentrations were measured with a high-sensitivity turbidimetric assay. Results: Median levels of CRP were 1.57 mg/l and 25% of both men and women had CRP values 43 mg/l. No differences were observed between men and women even after adjustment for age and body mass index (BMI). After patients with CRP values above the 97.5th percentile (n ¼ 31) had been excluded, CRP concentrations increased significantly with increasing levels of cardiovascular risk factors in both men and women. Men and women with metabolic syndrome showed significantly higher levels of CRP than their counterparts, even after adjustment for BMI and age. In a multiple regression analysis, BMI, triglycerides and fasting glucose were independent predictors of CRP in women and together explained 42% of its variance. In men, CRP was independently and positively associated to waist circumference, smoking, diastolic blood pressure, uric acid and triglycerides, and negatively associated to HDL-cholesterol. Altogether these variables explained 51% of its variability. Conclusions: The present study describes, for the first time, CRP concentrations in a sample that is representative of a Spanish Mediterranean community. CRP distribution and correlates are very similar to those reported previously in spite of the different lifestyle and nutritional habits, and the lower rates of cardiovascular diseases in our population.
Introduction
Chronic inflammation has been postulated as a key factor in the development and progression of atherosclerosis and cardiovascular disease. 1 Of the several inflammatory markers already studied, Creactive protein (CRP) is the one that is most consistently related to the risk of cardiovascular diseases in different populations. Hence, high CRP levels have been associated with a higher risk of cardiovascular morbidity and mortality in healthy subjects, selected high-risk subjects with traditional risk factors, and patients with cardiovascular diseases. [2] [3] [4] Additionally, some prospective studies have related higher CRP levels to a higher risk of developing other increasingly prevalent chronic diseases, such as diabetes 5 or hypertension. 6 This has led some authors to suggest that inflammatory markers be included in the definition of metabolic syndrome. 7 Furthermore, high-sensitivity CRP (hs-CRP) measurements have been shown to add to the predictive ability of traditional cardiovascular risk factors or the Framingham scoring estimates. 8, 9 This led the CDC and the American Heart Association to release a consensus statement about the use of CRP testing to assess risk of cardiovascular disease. 10 This same consensus outlined that before CRP measurements are extensively applied to identify subjects at risk, it is critically important to know how this marker is distributed in general and specific populations. To date, this kind of descriptions have been limited mainly to American 11, 12 or western European populations. 13 However, there is some evidence to suggest that distribution is different in some particular populations such as Japanese, 14 Indian Asians 15 or Black women. 16 Furthermore, the relationships established between inflammation and atherosclerotic risk factors are not consistent probably owing to baseline differences in the populations considered in the different studies. In fact, both genetic and lifestyle factors have been shown to affect the inflammatory response and, subsequently, the CRP levels. 17 Among these factors, Mediterranean diet has been shown to decrease inflammatory levels in a recent clinical trial. 18 Hence, we evaluated the distribution of serum hs-CRP levels in a Mediterranean sample that represents the adult population of Catalonia (Spain) and the relation of CRP to several cardiovascular risk factors in a cross-sectional survey of 1157 adult subjects from a Mediterranean community.
Material and methods

Subjects
The Health Survey of Catalonia (Encuesta de Salud de Catalunya, ESCA), performed in 2001, studied a representative sample of the non-institutionalized adult population of the northeast region of Spain, Catalonia. The random sort method was used to select a representative sample population. The units of the first phase of sampling were towns. These towns were randomly selected from each strata of town size in each of the eight health regions of Catalonia and the number of towns selected depended on the population of the region. In the second phase, the sampling units were individuals who were randomly selected from the National Population Register of the previously selected towns and stratified according to the population pyramid (age and gender). 20 The Health Examination Study of Catalonia was carried out in a randomly selected subsample of the participants in the ESCA. The data obtained were weighted to assure the representativeness of the genders and age groups. 20 This survey, based on detailed interviewed questionnaires with 165 items, aimed to collect information on different markers of health status in the population of Catalonia. A total of 8000 subjects from 18 to 74 years old participated in the 2001 ESCA. Of these, 1300 subjects participated in a second phase study, the Health Examination Study of Catalonia, in which additional health information and blood samples were obtained by the research team of the Health Plan Evaluation for Catalonia. 19 Methodological aspects of the Survey have been described elsewhere. 20 The present study includes a total of 1157 subjects (652 women and 505 men), for whom CRP concentrations were available. Among other data, the Health Examination Study of Catalonia provided information on the history of metabolic disorders, current therapies, and smoking habits of the studied population. Blood pressure levels, and anthropometrical and biochemical variables were also collected.
The Health Examination Study was approved by the Ethical Committee of the Department of Health of the Autonomous Government of Catalonia. All the subjects who participated in the study provided their fully informed written consent.
Methods
Height and body weight were determined in all subjects with light clothes and no shoes, and their body mass index (BMI) was then calculated. Waist circumference was measured midway between the lower rib margin and the iliac crest. Hip circumference was determined as the widest circumference measured on the great trochanter. The waist-to-hip ratio (WHR) was then calculated. Abdominal fat distribution was considered when the WHR was higher than 0.9 for women and higher than 1 for men according to the Spanish Society for the Study of Obesity. 21 Blood pressure was measured using a sphygmomanometer with the subject in a sitting position following the recommendations of the Spanish Hypertension Society. Measurements were taken twice with a 5-min interval between them and the average value was used for the analyses.
Blood samples were obtained in fasting conditions, preserved at 41C for less than 1 h during transportation and finally stored at À201C until they were determined. Plasma lipids (triglycerides, cholesterol) and high-, low-, and very low-density lipoprotein cholesterol (HDLc, LDLc and VLDLc, respectively), fasting glucose, and uric acid concentrations were measured by routine laboratory tests using automatic analysers. Measurements of insulin and CRP were centralized. Fasting insulin was determined by radioimmunoassay, using commercial kits (Amersham, Little Chalfont, UK). Serum levels of hs-CRP were measured by immunoturbidimetry (Quantex CRP ultra sensitive, Biokit SA, Barcelona, Spain). The lower limit of detection for this assay was 0.1 mg/l and its interassay and intrassay coefficients of variation (CV) were 1.76 and 0.9%, respectively. Diagnosis of metabolic syndrome was established following the defining criteria stated by the Adult Treatment Panel III 22 when three or more of the following criteria were present: (a) abdominal obesity: waist circumference 4102 cm in male and 488 cm in female subjects; (b) hypertriglyceridemia: X150 mg/dl; (c) low HDL-cholesterol: o40 mg/dl in male and o50 mg/dl in female subjects; (d) elevated blood pressure X130/85 mmHg; (e) fasting hyperglycemia: fasting plasma glucose 110 mg/dl. All subjects with previous diagnosis of diabetes or hypertension were considered to fit the respective criteria independently of the measured values.
Statistical analyses
Because the CRP concentrations were skewed, the values were log-transformed so as to approach a normal distribution and the geometric means are presented here. Percentiles of the CRP concentration were also calculated. Differences in mean values between groups were assessed by the unpaired t-test or the ANOVA test, and the CRP distribution in a Mediterranean cohort P García-Lorda et al contingency table w   2 -test was used to analyze qualitative traits. The study sample was divided into quartiles according to log CRP values. The cut-points were 0.67, 1.36 and 3.06 mg/l for men, and 0.77, 1.62 and 3.15 for women. Covariance analysis was used to adjust the variables, and the significance of the differences was assessed by the F-statistic.
Regression analyses were conducted for quantitative variables, and regression coefficients (r) were derived. A multiple stepwise regression analysis was conducted to identify the factors affecting CRP concentrations. The independent variables were age, weight, BMI, waist and hip circumferences, WHR, fasting glucose and insulin, systolic and diastolic blood pressure, uric acid and lipid levels.
Statistical significance was accepted at Po0.05 and all analyses were performed using the SPSS/PC package.
Results
The present study analyzed 1157 subjects, 652 women and 505 men. Table 1 shows the general characteristics of the studied sample. Additionally, 35% of the subjects smoked daily or occasionally (31% of the women and 40% of the men), 14% took aspirin or anti-inflammatory drugs on a regular basis, 6.1% took lipid-lowering drugs, 10.5% antihypertensive agents, and 4.2 antidiabetic drugs.
Mean and median levels of CRP were 3.08 and 1.57 mg/l, respectively. Percentiles of CRP concentration by sex and age are shown in Table 2 . Although women tend to show higher average CRP levels, no significant differences are observed in log CRP between men and women (1.6473.0 vs 1.5873.1 mg/l, respectively) even after adjustment for BMI and age. Only 2% of women were undergoing hormone replacement therapy (HRT) (n ¼ 16). CRP values are not significantly different in women under HRT compared to non-treated women, even after adjustment for age.
As high CRP concentrations may reflect an acute-phase response to infectious or inflammatory diseases, subjects on the 97.5th percentile for CRP levels (415 mg/dl) were excluded from the subsequent analysis (18 women and 13 men). Excluding these subjects, the mean and median CRP values are 2.43 and 1.51 mg/l, respectively.
Among the women, CRP values are significantly higher in the presence of hypertension, dyslipidemia, overweight, and CRP distribution in a Mediterranean cohort P García-Lorda et al abdominal fat distribution, and marginally significant for the presence of type 2 diabetes. However, there are no significant differences in CRP levels between smokers and non-smokers (Table 3) . After adjustment for age, the CRP values are still significantly different for the presence of overweight, hypertension, and abdominal fat distribution (Po0.001). Further adjustment for BMI does not change the results. Among men, CRP levels are significantly higher in those with overweight-obesity and in those with abdominal fat distribution as well as in the presence of hypertension and dyslipidemia. However, no differences are observed regarding the presence of type 2 diabetes or smoking (Table 3) . After adjustment for age, CRP values are significantly higher among those with overweight-obesity (Po0.001), abdominal fat distribution (Po0.001) and in the presence of smoking (P ¼ 0.039). Further adjustment for BMI does not change the results. In both sexes, CRP levels are significantly higher in the presence of metabolic syndrome (Figure 1 ). These differences are still significant even after adjustment for age and BMI (Po0.001).
Log-transformed CRP concentrations are significantly (Po0.0001) and positively associated with age (r ¼ 0.22), body weight (r ¼ 0.23), BMI (r ¼ 0.32), waist circumference (r ¼ 0.34), fasting glucose (r ¼ 0.19), insulin (r ¼ 0.16), uric acid (r ¼ 0.11), LDL-cholesterol (r ¼ 0.14) and triglycerides (r ¼ 0.19) in the whole population as well as in both genders separately. A negative relationship was observed between HDL-cholesterol and log-transformed CRP concentrations in both men (r ¼ À0.24; Po0.0001) and women (r ¼ À0.14; Po0.001). Cardiovascular risk factors are compared among CRP quartiles after adjustment for age for both men and women (Table 4) . In both genders, values of BMI, waist circumference, WHR, diastolic blood pressure, triglycerides, fasting glucose, insulin and uric acid increase from the lowest to the highest CRP quartile while HDLc concentrations decrease significantly. In women, systolic blood pressure increases significantly with increasing categories of CRP.
In a stepwise multivariate analysis, BMI, serum levels of triglycerides and fasting glucose are independent predictors of CRP in women, and together explain 42.2% of the variance in CRP. In men, waist circumference, present smoking status, diastolic blood pressure, uric acid, HDLcholesterol and serum triglycerides are all independently associated to CRP. Altogether they explain 51% of its variability. Table 5 displays the estimated percent change in CRP levels associated with each of these variables in both genders.
Discussion
We have described the distribution of hs-CRP concentrations in a cross-sectional sample from a Mediterranean community. Our sample is representative of the adult population of Catalonia and covers a wide age range.
In agreement with earlier reports, CRP levels depend significantly on age and increase gradually up to old age. In total, 5% of the population presented CRP levels higher than 10 mg/l. Data from American 12 and north European CRP distribution in a Mediterranean cohort P García-Lorda et al populations (France, former West Germany and Scotland) 13 have shown a similar distribution of CRP concentrations with the 50th CRP percentile around 1.5 mg/l for both genders. In our population, the geometric means and percentiles of the CRP distribution are very similar to those reported previously in spite of the different lifestyle and nutritional habits, and the different rates of cardiovascular diseases among cohorts. In fact, in the MONICA study, the largest ever cardiology study, which assessed 21 countries over a 10-year period, Catalonia showed one of the lowest average rates of coronary events in men and the lowest in women. 23 Of particular note in our Mediterranean sample was that 25% of both men and women had CRP concentrations 43 mg/l, which has been established by the AHA and the CDC guidelines as the clinical cut-point for high relative risk of future cardiovascular events. 10 Neither do we observe any differences in the CRP concentrations or distribution among men and women. The sex difference in CRP is controversial. Some cohorts have shown that CRP distributions are similar in both genders, 12, 13 whereas others have shown higher levels either in women 24, 25 or in men. 14 The reasons for such discrepancies are unclear but they may be explained, at least in part, by different proportions of postmenopausal women in the cohorts, as well as estrogen use. Hormone replacement therapy has been shown to increase CRP levels. 17, 26 In our sample, only 2% of the female population were using HRT, a much lower proportion than in other cohorts. 11 Furthermore, exclusion of HRT users did not modify the results. We excluded those subjects with CRP 415 mg/l, representing the 97.5th percentile (2.5% of the population). These subjects were excluded from the subsequent analysis so as not to include subjects with potential ongoing infectious or CRP distribution in a Mediterranean cohort P García-Lorda et al inflammatory transient conditions. However, it cannot be ruled out that these subjects present chronically high levels which may represent quite a high cardiovascular risk. The inclusion of these subjects did not substantially alter the conclusions of the study. The present study demonstrates that serum CRP concentrations are significantly and positively associated with such cardiovascular risk factors as BMI, waist circumference, fasting glucose and insulin, blood pressure, triglycerides, and LDL-cholesterol. It also shows that they are negatively associated with HDL-cholesterol in the total population. These relationships are similar in both men and women. However, adjustment for age dilutes some of these relationships, which finally means that total and LDL-cholesterol do not increase significantly with increasing quartiles of CRP either in men or women. In agreement with previous studies, 11, 27 indices of both total and abdominal adiposity (waist circumference and WHR) are strongly associated with significantly increased levels of CRP, and such associations are equally strong in women and men. Furthermore, the presence of abdominal fat distribution is accompanied by higher levels of CRP even after adjustment for BMI and age. This may be owing to the fact that omental adipose tissue secretes more IL-6 than subcutaneous depots, leading to a higher hepatic synthesis of inflammatory markers such as CRP. 28 The relationship between CRP and cardiovascular risk factors has not always been consistent among studies. The discrepancies may reflect differences in the populations studied, as well as differences in the frequency of some important determinants of inflammatory levels such as overweight, abdominal obesity, diabetes, smoking or metabolic syndrome. In our study, the presence of hypertension, overweight and abdominal fat distribution is accompanied by significantly increased levels of CRP in women, even after adjustment for age and BMI. In men, not only does overweight and abdominal fat distribution increase this parameter but also the presence of a current smoking habit. Furthermore, in accordance with previous studies, CRP levels increases significantly in those subjects with metabolic syndrome 4, 29 with a mean increase of 82 and 130% in CRP levels in men and women, respectively. Determinants of CRP are also different among genders. Surprisingly, smoking is not related to CRP concentrations in women but is a strong predictor in men. A study performed in a large survey 30 showed that smoking was strongly associated to systemic markers of inflammation in men but not in women. Whether this reflects a sexual dimorphism in inflammatory reaction associated to smoking or just the consequence of a lower prevalence of smokers among women cannot be determined from the present study.
The main limitation of the present analysis is its crosssectional nature, which does not enable any causal relationships to be established. Whether chronic inflammation is involved in the pathophysiology of metabolic syndrome or is just a consequence of the metabolic abnormalities, such as hyperinsulinemia, included in this syndrome remains controversial. Further longitudinal designs are needed to clarify this. Further, several factors that have been reported to affect CRP concentrations, such as socioeconomic status, alcohol consumption or physical activity, have not been included in the present analysis. Additionally, only single measurements of CRP were performed. The strengths of the present study lie in the representativeness of the sample of the adult population of Catalonia and the use of one single highsensitive CRP assay.
Although CRP is an extremely sensitive marker of the acute phase response, it is completely unspecific and can be influenced by a variety of factors and disease states. How CRP distribution can be similar among populations of different cardiovascular risks, as well as between men and women, should be clarified. In any case, the distribution of a risk marker must be described if subjects at high risk are to be identified. The present data from a representative Mediterranean population may be useful for assessing cardiovascular risk in clinical practice.
